BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 17338363)

  • 1. [Sildenafil influence on the level of pulmonary artery pressure, bronchial patency and endothelial function during the action of risk factors for development of cardiorespiratory pathology].
    Baksheev VI; Kolomoets NM; Kartashov VT; Tursunova GF
    Voen Med Zh; 2006 Dec; 327(12):21-3. PubMed ID: 17338363
    [No Abstract]   [Full Text] [Related]  

  • 2. Sildenafil: a definitive NO in COPD.
    Vonk-Noordegraaf A; Boerrigter BG
    Eur Respir J; 2013 Oct; 42(4):893-4. PubMed ID: 24081756
    [No Abstract]   [Full Text] [Related]  

  • 3. Sildenafil for COPD: a randomized crossover trial.
    Bull T; Badesch DB
    COPD; 2012 Jun; 9(3):211-2. PubMed ID: 22587530
    [No Abstract]   [Full Text] [Related]  

  • 4. Should we administer sildenafil to patients with obstructive pulmonary disease and pulmonary hypertension? No.
    Namendys-Silva SA; Hernández-Garay M
    Am J Respir Crit Care Med; 2010 Nov; 182(9):1206; author reply 1206-7. PubMed ID: 21041564
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical characteristics and outcome of 13 dogs with pulmonary arterial hypertension (PH) treated with sildenafil.
    Moreno HJ
    J Vet Intern Med; 2007; 21(6):1165. PubMed ID: 18196719
    [No Abstract]   [Full Text] [Related]  

  • 6. Sildenafil citrate for the treatment of patients with cardiovascular diseases with exclusion of coronary artery disease and hypertrophic subaortic stenosis. Its beneficial effect on patients chronic Chagas's and diabetic cardioneuromyopathies, hypertensive and hypertrophic cardiomyopathies, with or without chronic congestive heart failure.
    Iosa D
    Rev Fac Cien Med Univ Nac Cordoba; 2003; 60(2):23-33. PubMed ID: 14763430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should we administer sildenafil to patients with acute respiratory distress syndrome? No.
    Namendys-Silva SA; Hernández-Garay M; Rivero-Sigarroa E
    Intensive Care Med; 2010 Jun; 36(6):1102-3; author reply 1104-5. PubMed ID: 20333352
    [No Abstract]   [Full Text] [Related]  

  • 8. Sildenafil may facilitate weaning in mechanically ventilated COPD patients: a report of three cases.
    Stanopoulos I; Manolakoglou N; Pitsiou G; Trigonis I; Tsiata EA; Boutou AK; Kontou PK; Argyropoulou P
    Anaesth Intensive Care; 2007 Aug; 35(4):610-3. PubMed ID: 18020085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular risk factors determine erectile and arterial function response to sildenafil.
    Solomon H; Wierzbicki AS; Lumb PJ; Lambert-Hammill M; Jackson G
    Am J Hypertens; 2006 Sep; 19(9):915-9. PubMed ID: 16942933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resolution of high uterine artery pulsatility index and notching following sildenafil citrate treatment in a growth-restricted pregnancy.
    Lin TH; Su YN; Shih JC; Hsu HC; Lee CN
    Ultrasound Obstet Gynecol; 2012 Nov; 40(5):609-10. PubMed ID: 22350857
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of sildenafil and nitric oxide in the management of hypoxemia owing to pulmonary arteriovenous fistulas after total cavopulmonary connection.
    Bhate S; Rossiter-Thornton M; Cooper SG; Gillis J; Cole AD; Sholler GS; Chard RB; Winlaw DS
    J Thorac Cardiovasc Surg; 2008 Feb; 135(2):446-8. PubMed ID: 18242289
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension.
    Michelakis ED; Tymchak W; Noga M; Webster L; Wu XC; Lien D; Wang SH; Modry D; Archer SL
    Circulation; 2003 Oct; 108(17):2066-9. PubMed ID: 14568893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sildenafil in idiopathic pulmonary fibrosis.
    Rossi GP; Seccia TM
    N Engl J Med; 2010 Nov; 363(22):2169-70; author reply 2170-1. PubMed ID: 21105803
    [No Abstract]   [Full Text] [Related]  

  • 14. [How to treat erectile dysfunction complicated with cardiovascular disease using sildenafil citrate?].
    Nishi S
    Nihon Rinsho; 2002 Jun; 60 Suppl 6():504-7. PubMed ID: 12166213
    [No Abstract]   [Full Text] [Related]  

  • 15. Sildenafil to improve respiratory rehabilitation outcomes in COPD: a controlled trial.
    Blanco I; Santos S; Gea J; Güell R; Torres F; Gimeno-Santos E; Rodriguez DA; Vilaró J; Gómez B; Roca J; Barberà JA
    Eur Respir J; 2013 Oct; 42(4):982-92. PubMed ID: 23429918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sildenafil treatment of unilateral pulmonary edema and pulmonary hypertension in pulmonary artery agenesis].
    Rodríguez-Gómez F; Martín I; Sánchez A; Pujol E
    Rev Esp Cardiol; 2006 Dec; 59(12):1347-9. PubMed ID: 17194435
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute effects of sildenafil on exercise pulmonary hemodynamics and capacity in patients with COPD.
    Holverda S; Rietema H; Bogaard HJ; Westerhof N; Postmus PE; Boonstra A; Vonk-Noordegraaf A
    Pulm Pharmacol Ther; 2008; 21(3):558-64. PubMed ID: 18342559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic and gas exchange effects of sildenafil in patients with chronic obstructive pulmonary disease and pulmonary hypertension.
    Blanco I; Gimeno E; Munoz PA; Pizarro S; Gistau C; Rodriguez-Roisin R; Roca J; Barberà JA
    Am J Respir Crit Care Med; 2010 Feb; 181(3):270-8. PubMed ID: 19875684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sildenafil in idiopathic pulmonary fibrosis.
    Mubarak K
    N Engl J Med; 2010 Nov; 363(22):2170; author reply 2170-1. PubMed ID: 21105802
    [No Abstract]   [Full Text] [Related]  

  • 20. Right ventricular diastolic dysfunction and the acute effects of sildenafil in pulmonary hypertension patients.
    Gan CT; Holverda S; Marcus JT; Paulus WJ; Marques KM; Bronzwaer JG; Twisk JW; Boonstra A; Postmus PE; Vonk-Noordegraaf A
    Chest; 2007 Jul; 132(1):11-7. PubMed ID: 17625080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.